Innovative NeuroTechnologies, Inc. attends the annual VC in the OC 2010 and OCTANe Innovation Showcase at the Hyatt Regency Irvine.

PHIGroup To Assist Innovative NeuroTechnologies to Access European Capital Markets LOS ANGELES and FRANKFURT, Germany, Dec. 30, 2009 -- PHIGroup, Inc. (OTCBB:PHIE - News) (Frankfurt:PR7) (XETRA:PR7 - News) (WKN A0RNQV), a company engaged in the development and management of real estate properties, mining interests and consulting, merger and acquisition advisory services, announced today that the company has agreed to assist Innovative NeuroTechnologies, Inc. http://www.innovneurotech.com (INT) to list its shares on a leading European stock market and arrange funding for further development and growth. Innovative NeuroTechnologies is a biotechnology company based in Irvine, CA engaged in the early-stage clinical development of novel therapeutic strategies for major human central nervous system disorders, particularly in the area of neurodegeneration. According to the agreement, PHIGroup will retain approximately 15% equity in INT as part of the compensation for the services rendered. INT is currently focusing its efforts on such diseases as Alzheimer's disease Parkinson's disease, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), Huntington’s disease, stroke and multiple sclerosis. These are typically fatal neurodegenerative disorders that are currently untreatable and share many characteristics, which make them particularly amenable to INT's expertise and technologies. Shawn Mojtahedian, Ph.D., Founder, Director and Chief Scientific Officer of Innovative NeuroTechnologies, said, ”We are very pleased to have PHIGroup assist INT in its current fund raising efforts in the European Capital Markets (i.e., the Frankfurt Stock Exchange), especially in the present very difficult economic environment for early-stage capital for biotechnology companies. We look forward to working with PHIGroup.” PHIGroup Chairman and CEO Henry Fahman said, "We are delighted to assist Innovative NeuroTechnologies and its management team in positioning the company for further development and growth. We believe by listing on a leading European stock market, INT will able to effectively access capital and execute its business strategy.” About PHIGroup, Inc. PHIGroup develops real estate and natural resources, provides M&A advisory and consulting services and invests in special situations. PHIGroup, which specializes in raising capital and helping take companies public, is developing Philand Ranch, one of the largest master planned communities in Vietnam. This project includes Pointe91, a luxury resort and premium residential community in Quang Nam province in central Vietnam. PHIGroup is also engaged in mining in Southeast Asia and Haiti (PHIMining Group, Inc.) (Pink Sheets:PHIG - News) (www.phimining.com). Website: www.phiglobal.com. About Innovative NeuroTechnologies INT is primarily an early-stage clinical development biotechnology company that seeks novel therapeutic solutions (i.e., biopharmaceuticals, stem cells) for major human central nervous system disorders, particularly in the area of neurodegeneration. The company presently focuses its main efforts on Alzheimer's disease with interest in therapeutic solutions for Parkinson's disease, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), Huntington’s disease, frontotemporal lobar dementias (FTLDs or Picks’s disease), stroke and multiple sclerosis. These are typically fatal neurodegenerative disorders that are currently untreatable and share many characteristics, which make them particularly amenable to INT's expertise and employed technologies. http://www.innovneurotech.com/ Safe Harbor: This news release contains forward-looking statements that are subject to certain risks and uncertainties Such forward-looking statements are based upon management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected, on the basis of such forward-looking statements. Henry Fahman 714-843-5455 henry@phiglobal.com

Innovative NeuroTechnologies, Inc. registered to attend the upcoming J.P. Morgan 28th Annual Healthcare Conference on January 11-14, 2010 at the Westin St. Francis Hotel in San Francisco, CA. http://www.jpmorgan.com/pages/jpmorgan/investbk/global/na/usconferences/hc

Innovative NeuroTechnologies, Inc. registered to attend the upcoming 4th Annual BIOCOM Investor Conference on October 26-27th at the Hyatt Regency La Jolla at Aventine in San Diego, CA.

Shawn Mojtahedian, Ph.D., Founder, Director & Chief Scientific Officer of Innovative NeuroTechnologies, Inc., is interviewed by Jenn Karlmann of InLab Ventures at the 7th Annual San Diego Venture Summit on Wednesday, September 16, 2009 at the Hilton Bayfront Hotel in San Diego, CA. http://inlabventures.smugmug.com/Videos/SD-Venture-Group/9956138_rtQW8#679804346_7Gpq3-A-LB

Shawn Mojtahedian, Ph.D., Founder, Director & Chief Scientific Officer of Innovative NeuroTechnologies, Inc., is co-authored on a Correspondence article entitled "Is it virtuous to be virtual? The VC viewpoint" published in the journal Nature Biotechnology (October 2009, Volume 27, Number 10, pp. 886-888). http://www.nature.com/nbt/journal/v27/n10/index.html#nv

Innovative NeuroTechnologies, Inc. registered to attend the upcoming Southern California Biomedical Council (SoCalBio) 11th Annual Investor and Partnership Conference on Thursday, September 17, 2009 at the Loews Santa Monica Beach Hotel in Santa Monica, CA.

Innovative NeuroTechnologies, Inc. registered to attend the upcoming Foley's Life Sciences Conference, "Cultivating New Opportunities: Short-Term Strategies for Long-Term Growth," Wednesday, September 30, 2009 at the Hyatt Regency La Jolla at Aventine in San Diego, CA.

Innovative NeuroTechnologies, Inc. registered to attend the upcoming 7th Annual San Diego Venture Summit on Wednesday, September 16, 2009 at the Hilton Bayfront Hotel in San Diego, CA.

Innovative NeuroTechnologies, Inc. receives 2009 Best of Irvine Award FOR IMMEDIATE RELEASE U.S. Commerce Association’s Award Plaque Honors the Achievement WASHINGTON D.C., June 8, 2009 -- Innovative NeuroTechnologies, Inc. has been selected for the 2009 Best of Irvine Award in the Commercial Nonphysical Research category by the U.S. Commerce Association (USCA). The USCA "Best of Local Business" Award Program recognizes outstanding local businesses throughout the country. Each year, the USCA identifies companies that they believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and community. Various sources of information were gathered and analyzed to choose the winners in each category. The 2009 USCA Award Program focused on quality, not quantity. Winners are determined based on the information gathered both internally by the USCA and data provided by third parties. About U.S. Commerce Association (USCA) U.S. Commerce Association (USCA) is a Washington D.C. based organization funded by local businesses operating in towns, large and small, across America. The purpose of USCA is to promote local business through public relations, marketing and advertising. The USCA was established to recognize the best of local businesses in their community. Our organization works exclusively with local business owners, trade groups, professional associations, chambers of commerce and other business advertising and marketing groups. Our mission is to be an advocate for small and medium size businesses and business entrepreneurs across America. SOURCE: U.S. Commerce Association CONTACT: U.S. Commerce Association Email: PublicRelations@us-ca.org URL: http://www.us-ca.org